Latest news

MDD Fact sheets

Posted on 08.11.2015

The scope of any legislative measure must be as clear as possible to avoid potential confusion and fragmentation in its implementation.

Safer, timely and life-changing: medtech innovation is good for patients and policymakers alike

Posted on 06.11.2015

The key to success in the medical technology industry has been continuous innovation and a dedication to research and development.

Approval system: bringing new technology to market

Posted on 05.11.2015

The recent PIP breast implant incident has made it crystal clear that healthcare actors must pull together to ensure that such a case of fraud never happens again.

Medical devices and pharmaceuticals: Two different worlds in one health setting

Posted on 04.11.2015

While the medical technology and pharmaceutical industries are both essential to health, it is important to acknowledge that the two are extremely different.

Safer, healthier patients with the fastest access to the latest life-saving technology

Posted on 03.11.2015

The European Union defines patient safety as: “Freedom for a patient from unnecessary harm or potential harm associated with healthcare”.

Advocacy activities related to MD and IVD Regulations

Posted on 03.11.2015

In Vitro Diagnostic Medical Devices Directive

Posted on 07.09.2015

The safety and performance of in vitro diagnostic devices are regulated in the EU by the 1998 In Vitro Diagnostic Medical Devices Directive (IVDD). This sets a framework for manufacturers and for authorised representatives who seek to place IVD products on EU market. It aims to ensure that IVD devices comply with stringent standards for quality and safety, and produce reliable data to be used for diagnostic purposes.

The environmental impact of medtech

Posted on 04.09.2015

All industries leave an environmental footprint. The European medical technology sector is committed to being as low-impact and green as possible, an approach that complements its efforts to improve the health and welfare of citizens. The medtech industry recognises its duty to act responsibly and work in a sustainable way. MedTech Europe gives feedback to environmental regulators while also providing information on compliance with regulations.

Transparent and ethical relationships

Posted on 31.08.2015

The very nature of the medtech industry implies a close relationship with physicians, nurses, lab technicians and other healthcare professionals (HCPs). Interactions with HCPs and healthcare organisations (HCOs), such as hospitals and clinics, are a key part of the day-to-day activities of medtech companies.

Public Procurement

Posted on 31.08.2015

Public procurement is the acquisition of goods and services on behalf of a public authority like a government agency, or other bodies such as hospitals and other healthcare providers. A large part of Europe’s medical technologies are purchased using procurement processes.

International Organisations

Posted on 29.08.2015

MedTech Europe works closely with global organizations whose activities affect the medical devices and IVDs sectors.

Conference Vetting System

Posted on 29.08.2015

Eucomed’s Conference Vetting System is an independently managed system that reviews the compliance of third-party educational conferences with the Eucomed Code of Ethical Business Practice, based on clear and objective criteria.